These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 31644488

  • 21. The Addition of C-Reactive Protein and von Willebrand Factor to Model for End-Stage Liver Disease-Sodium Improves Prediction of Waitlist Mortality.
    Starlinger P, Ahn JC, Mullan A, Gyoeri GP, Pereyra D, Alva-Ruiz R, Hackl H, Reiberger T, Trauner M, Santol J, Simbrunner B, Mandorfer M, Berlakovich G, Kamath PS, Heimbach J.
    Hepatology; 2021 Sep; 74(3):1533-1545. PubMed ID: 33786862
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.
    Kim WR, Mannalithara A, Heimbach JK, Kamath PS, Asrani SK, Biggins SW, Wood NL, Gentry SE, Kwong AJ.
    Gastroenterology; 2021 Dec; 161(6):1887-1895.e4. PubMed ID: 34481845
    [Abstract] [Full Text] [Related]

  • 27. Validating a novel score based on interaction between ACLF grade and MELD score to predict waitlist mortality.
    Abdallah MA, Kuo YF, Asrani S, Wong RJ, Ahmed A, Kwo P, Terrault N, Kamath PS, Jalan R, Singal AK.
    J Hepatol; 2021 Jun; 74(6):1355-1361. PubMed ID: 33326814
    [Abstract] [Full Text] [Related]

  • 28. Integrated model for end-stage liver disease maybe superior to some other model for end-stage liver disease-based systems in addition to Child-Turcotte-Pugh and albumin-bilirubin scores in patients with hepatitis B virus-related liver cirrhosis and spontaneous bacterial peritonitis.
    Chen PC, Chen BH, Huang CH, Jeng WJ, Hsieh YC, Teng W, Chen YC, Ho YP, Sheen IS, Lin CY.
    Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1256-1263. PubMed ID: 31498284
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
    Kwong AJ, Lai JC, Dodge JL, Roberts JP.
    Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
    [Abstract] [Full Text] [Related]

  • 31. Model for End stage Liver Disease (MELD) and Child-Turcotte-Pugh (CTP) scores: Ability to predict mortality and removal from liver transplantation waiting list due to poor medical conditions.
    Rahimi-Dehkordi N, Nourijelyani K, Nasiri-Tousi M, Ghodssi-Ghassemabadi R, Azmoudeh-Ardalan F, Nedjat S.
    Arch Iran Med; 2014 Feb; 17(2):118-21. PubMed ID: 24527973
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Disability in patients with end-stage liver disease: Results from the functional assessment in liver transplantation study.
    Samoylova ML, Covinsky KE, Haftek M, Kuo S, Roberts JP, Lai JC.
    Liver Transpl; 2017 Mar; 23(3):292-298. PubMed ID: 27884053
    [Abstract] [Full Text] [Related]

  • 34. Model for end-stage liver disease-sodium and survival benefit in liver transplantation.
    Vitale A, Bertacco A, Gambato M, D'Amico F, Morales RR, Frigo AC, Zanus G, Burra P, Angeli P, Cillo U.
    Transpl Int; 2013 Feb; 26(2):138-44. PubMed ID: 23194386
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality.
    Salvalaggio PR, Afonso RC, Pereira LA, Ferraz-Neto BH.
    Transplant Proc; 2012 Oct; 44(8):2283-5. PubMed ID: 23026574
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Analysis of mortality prognostic factors using model for end-stage liver disease with incorporation of serum-sodium classification for liver cirrhosis complications: A retrospective cohort study.
    Kim Y, Kim K, Jang I.
    Medicine (Baltimore); 2019 Nov; 98(45):e17862. PubMed ID: 31702650
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.